Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine analgosedation in newborn infants during neonatal intensive care
2015-002506-37Phase 3Active
- Sponsor
- Region Skåne
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of dexmedetomidine in critical illness and Not applicable; "congenital" alone does not specify any single disease, sponsored by Region Skåne. Primary endpoint: Pharmacokinetics of dexmedetomidine. Started Sep 2019; status: active.
02
Drugs
dexmedetomidine
03
Conditions
critical illnessNot applicable; "congenital" alone does not specify any single disease.
Beyond the preview
Go deeper on 2015-002506-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002506-37.